Informed decision making changes test preferences for colorectal cancer screening in a diverse population

Annals of Family Medicine

Volumn 8, Issue 2, 2010, Pages 141-150

  Shokar, Navkiran K ^a   Carlson, Carol A ^a   Weller, Susan C ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Colorectal neoplasms; Decision making; Ethnic groups; Mass screening; Patient preference; Physician patient communication

Indexed keywords

AFRICAN AMERICAN; AGED; ARTICLE; ATTITUDE TO HEALTH; CAUCASIAN; CHEMISTRY; COGNITION; COLONOSCOPY; COLORECTAL TUMOR; CROSS-SECTIONAL STUDY; DECISION MAKING; DIAGNOSTIC TEST; DOCTOR PATIENT RELATION; FECES; FEMALE; HISPANIC; HUMAN; INTERVIEW; MALE; METHODOLOGY; MIDDLE AGED; PSYCHOLOGICAL ASPECT; UNITED STATES;

AFRICAN AMERICANS; AGED; CHOICE BEHAVIOR; COGNITION; COLONOSCOPY; COLORECTAL NEOPLASMS; CROSS-SECTIONAL STUDIES; DECISION MAKING; DIAGNOSTIC TESTS, ROUTINE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FECES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HISPANIC AMERICANS; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; PHYSICIAN-PATIENT RELATIONS; TEXAS;

EID: 77949278271     PISSN: 15441709     EISSN: 15441717     Source Type: Journal    
DOI: 10.1370/afm.1054     Document Type: Article

References (58)

1. Ries L, Wingo P, Miller D, et al. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Am Cancer Soc. 2000;88:2398-2424.
2. American Cancer Society. Cancer Facts and Figures, 2008. http://www.cancer.org/downloads/STT/2008CAFFfinalsecured.pdf.
3. Levin B, Lieberman DA, McFarland B, et al. American Cancer Society Colorectal Cancer Advisory Group. US Multi-Society Task Force. American College of Radiology Colon Cancer Committee. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008;58(3):130-160.
4. Whitlock E, Lin J, Liles E, Beil T, Fu R. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149(9):638-658 & W117-W122.
5. Zoorob R, Anderson R, Cefalu C, Sidani M. Cancer screening guidelines. Am Fam Physician. 2001;63(6):1101-1112.
6. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348(9040):1472-1477.
7. Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348(9040):1467-1471.
8. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328(19):1365-1371.
9. Müller AD, Sonnenberg A. Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. Arch Intern Med. 1995;155(16):1741-1748.
10. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326(10):653-657.
11. Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst. 1993;85(16):1311-1318.
12. Maciosek MV, Solberg LI, Coffield AB, Edwards NM, Goodman MJ. Colorectal cancer screening: health impact and cost effectiveness. Am J Prev Med. 2006;31(1):80-89.
13. Anderson LM, May DS. Has the use of cervical, breast, and colorectal cancer screening increased in the United States? Am J Public Health. 1995;85(6):840-842.
14. Breen N, Wagener DK, Brown ML, Davis WW, Ballard-Barbash R. Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst. 2001;93(22):1704-1713.
15. Ruffin MT IV, Gorenflo DW, Woodman B. Predictors of screening for breast, cervical, colorectal, and prostatic cancer among community-based primary care practices. J Am Board Fam Pract. 2000;13(1):1-10.
16. Seeff L, Nadel M, Blackman D; Centers for Disease Control and Prevention (CDC). Colorectal cancer test use among persons aged > or=50 years-United States, 2001. MMWR Morb Mortal Wkly Rep. 2003;52(10):193-196.
17. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2006. CA Cancer J Clin. 2006;56(1):11-25, quiz 49-50.
18. US Department of Health and Human Services. Healthy People 2010, Conference Edition, Section 3-12. http://www.health.gov/healthypeople. Accessed Jan 2000.
19. Special section: colorectal cancer and early detection. In: Cancer Facts and Figures. Atlanta, GA: American Cancer Society; 2002:20-27.
20. Shapiro JA, Seeff LC, Thompson TD, Nadel MR, Klabunde CN, Vernon SW. Colorectal cancer test use from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev. 2008;17(7):1623-1630.
21. Shokar NK, Carlson CA, Weller SC. Prevalence of colorectal cancer testing and screening in a multiethnic primary care population. J Community Health. 2007;32(5):311-323.
22. Swan J, Breen N, Coates RJ, Rimer BK, Lee NC. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer. 2003;97(6):1528-1540.
23. Cooper G, Fortinsky R, Hapke R, Landefeld C. Factors Associated with the use of flexible sigmoidoscopy as a screening test for the detection of colorectal carcinoma by primary care physicians. Cancer. 1998:1476-1481.
24. Hawley ST, Levin B, Vernon SW. Colorectal cancer screening by primary care physicians in two medical care organizations. Cancer Detect Prev. 2001;25(3):309-318.
25. Ling BS, Moskowitz MA, Wachs D, Pearson B, Schroy PCI. Attitudes toward colorectal cancer screening tests. J Gen Intern Med. 2001;16(12):822-830.
26. Schroy PC III, Geller AC, Crosier Wood M, et al. Utilization of colorectal cancer screening tests: a 1997 survey of Massachusetts internists. Prev Med. 2001;33(5):381-391.
27. Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137(2):132-141.
28. Greiner KA, Engelman KK, Hall MA, Ellerbeck EF. Barriers to colorectal cancer screening in rural primary care. Prev Med. 2004; 38(3):269-275.
29. Katz M, James A, Pignone M, et al. Colorectal cancer screening among African American church members: A qualitative and quantitative study of patient-provider communication. BMC Public Health. 2004;4(62):1-8.
30. Tessaro I, Magone C, Pawar V. Knowledge, barriers, and predictors of colorectal cancer screening in an Appalachian church population. Prev Chronic Dis. 2006;3(4):1-11.
31. DeBourcy AC, Lichtenberger S, Felton S, Butterfield KT, Ahnen DJ, Denberg TD. Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening. J Gen Intern Med. 2008;23(2):169-174.
32. Frew E, Wolstenholme J, Whynes D. Mass population screening for colorectal cancer: factors influencing subjects' choice of screening test. J Health Serv Res Policy. 2001;6(2):85-91.
33. Griffith JM, Lewis CL, Brenner AR, Pignone MP. The effect of offering different numbers of colorectal cancer screening test options in a decision aid: a pilot randomized trial. BMC Med Inform Decis Mak. 2008;8:4.
34. Leard LE, Savides TJ, Ganiats TG. Patient preferences for colorectal cancer screening. J Fam Pract. 1997;45(3):211-218.
35. Marshall DA, Johnson FR, Phillips KA, Marshall JK, Thabane L, Kulin NA. Measuring patient preferences for colorectal cancer screening using a choice-format survey. Value Health. 2007;10(5):415-430.
36. Pignone M, Bucholtz D, Harris R. Patient preferences for colon cancer screening. J Gen Intern Med. 1999;14(7):432-437.
37. Schroy PC III, Lal S, Glick JT, Robinson PA, Zamor P, Heeren TC. Patient preferences for colorectal cancer screening: how does stool DNA testing fare? Am J Manag Care. 2007;13(7):393-400.
38. Wolf AM, Schorling JB. Does informed consent alter elderly patients' preferences for colorectal cancer screening? Results of a randomized trial. J Gen Intern Med. 2000;15(1):24-30.
39. Gagne RM. The acquisition of knowledge. Psychol Rev. 1962;69:355-365.
40. Salkeld GP, Solomon MJ, Short L, Ward J. Measuring the importance of attributes that influence consumer attitudes to colorectal cancer screening. ANZ J Surg. 2003;73(3):128-132.
41. Shokar N, Weller S, Vernon S. Cancer and Colorectal Cancer: Knowledge, beliefs and Screening Preferences of a Diverse Population. Fam Med. 2005;31(5):341-347.
42. Centers for Disease Control. Screen for Life. http://www.cdc.gov/cancer/screenforlife. Accessed Jan 3, 2005.
43. American Society for Gastrointestinal Endoscopy. Common Complication of Colonoscopy. http://www.asge.org/nspages/practice/patientcare/complications.cfm. Accessed Jan 3, 2005.
44. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med. 2000;343(3):162-168.
45. Blakeborough A, Sheridan MB, Chapman AH. Complications of barium enema examinations: a survey of UK Consultant Radiologists 1992 to 1994. Clin Radiol. 1997;52(2):142-148.
46. SPSS for Windows [computer software]. Release 14.0.1. Chicago, IL: SPSS, Inc; 2001.
47. Weller S. Cultural consensus theory: Applications and frequently asked questions. Field Meth. 2007;19(4):339-368.
48. Weller S, Romney A. Systematic Data Collection. Qualitative Research Methods Series 10. Vol 10. Thousand Oaks, CA: Sage Publications; 1988.
49. Nunnally J. Psychometric Theory. New York, NY: McGraw Hill; 1978.
50. Zajonc R. A note on group judgement and group size. Hum Relat. 1962;15(2):117-180.
51. Fleiss J. Statistical Methods For Rates and Proportions. Malden, MA: Wiley Interscience; 1981;150.
52. Weller SC, Mann NC. Assessing rater performance without a gold standard using consensus theory. Med Decis Making. 1997;17(1):71-79.
53. Hawley ST, Volk RJ, Krishnamurthy P, Jibaja-Weiss M, Vernon SW, Kneuper S. Preferences for colorectal cancer screening among racially/ethnically diverse primary care patients. Med Care. 2008;46(9)(Suppl 1):S10-S16.
54. Hack TF, Degner LF, Watson P, Sinha L. Do patients benefit from participating in medical decision making? Longitudinal follow-up of women with breast cancer. Psychooncology. 2006;15(1):9-19.
55. Street RL Jr, Voigt B. Patient participation in deciding breast cancer treatment and subsequent quality of life. Med Decis Making. 1997;17(3):298-306.
56. Wolf MS, Baker DW, Makoul G. Physician-patient communication about colorectal cancer screening. J Gen Intern Med. 2007;22(11):1493-1499.
57. Stange KC, Zyzanski SJ, Jaén CR, et al. Illuminating the 'black box'. A description of 4454 patient visits to 138 family physicians. J Fam Pract. 1998;46(5):377-389.
58. Stange KC, Flocke SA, Goodwin MA. Opportunistic preventive services delivery. Are time limitations and patient satisfaction barriers? J Fam Pract. 1998;46(5):419-424.